ENTA
ENANTA PHARMACEUTICALS INC
-0.07 (-0.55%)12.63USD109K成交股數368M市值–本益比(近四季)5.6股價營收比-21.6%營收年增(近四季)2026-11-16下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-08 | 08-10 | Rottinghaus Scott T. | Chief Medical Officer | F 繳稅扣股 | 1.5K | 13.34 | 20K | 23.8K | SEC |
| 2026-02-12 | 02-13 | Luly Jay R. | President and CEO | A 獲配股票 | 15.2K | – | – | 878K | SEC |
| 2026-02-12 | 02-13 | Or Yat Sun | Chief Scientific Officer | F 繳稅扣股 | 3.4K | 14.25 | 49K | 375K | SEC |
| 2026-02-12 | 02-13 | Luly Jay R. | President and CEO | F 繳稅扣股 | 6.2K | 14.25 | 88K | 872K | SEC |
| 2026-02-12 | 02-13 | Luly Jay R. | President and CEO | A 獲配股票 | 4.8K | – | – | 863K | SEC |
| 2026-02-12 | 02-13 | Luu Brendan | Chief Business Officer | F 繳稅扣股 | 3.3K | 14.25 | 46K | 41.6K | SEC |
| 2026-02-12 | 02-13 | Luu Brendan | Chief Business Officer | A 獲配股票 | 1.6K | – | – | 39.9K | SEC |
| 2026-02-12 | 02-13 | Or Yat Sun | Chief Scientific Officer | A 獲配股票 | 1.6K | – | – | 373K | SEC |
| 2026-02-12 | 02-13 | Or Yat Sun | Chief Scientific Officer | A 獲配股票 | 5.2K | – | – | 378K | SEC |
| 2026-02-12 | 02-13 | Kieffer Tara Lynn | Chief Product Strategy Officer | A 獲配股票 | 1.6K | – | – | 32.2K | SEC |
| 2026-02-12 | 02-13 | Rottinghaus Scott T. | Chief Medical Officer | F 繳稅扣股 | 3.4K | 14.25 | 49K | 25.3K | SEC |
| 2026-02-12 | 02-13 | Kowalsky Matthew Paul | Chief Legal Officer | A 獲配股票 | 4.2K | – | – | 5.5K | SEC |
| 2026-02-12 | 02-13 | Kieffer Tara Lynn | Chief Product Strategy Officer | F 繳稅扣股 | 3.3K | 14.25 | 46K | 33.9K | SEC |
| 2026-02-12 | 02-13 | Luu Brendan | Chief Business Officer | A 獲配股票 | 5.0K | – | – | 44.9K | SEC |
| 2026-02-12 | 02-13 | Rottinghaus Scott T. | Chief Medical Officer | A 獲配股票 | 1.6K | – | – | 23.4K | SEC |
| 2026-02-12 | 02-13 | Kowalsky Matthew Paul | Chief Legal Officer | A 獲配股票 | 1.3K | – | – | 1.3K | SEC |
| 2026-02-12 | 02-13 | Kowalsky Matthew Paul | Chief Legal Officer | F 繳稅扣股 | 1.9K | 14.25 | 27K | 3.6K | SEC |
| 2026-02-12 | 02-13 | Rottinghaus Scott T. | Chief Medical Officer | A 獲配股票 | 5.2K | – | – | 28.7K | SEC |
| 2026-02-12 | 02-13 | Kieffer Tara Lynn | Chief Product Strategy Officer | A 獲配股票 | 5.0K | – | – | 37.2K | SEC |
| 2025-12-05 | 12-05 | Capps Kathleen S. | See Remarks | S 公開市場賣出 | 323 | 14.23 | 5K | 8.4K | SEC |
| 2025-12-05 | 12-05 | Luly Jay R. | President and CEO | S 公開市場賣出 | 4.7K | 14.23 | 67K | 858K | SEC |
| 2025-12-05 | 12-05 | Trout Harry R. III | See Remarks | S 公開市場賣出 | 542 | 14.23 | 8K | 16.3K | SEC |
| 2025-12-05 | 12-05 | Rottinghaus Scott T. | Chief Medical Officer | S 公開市場賣出 | 798 | 14.23 | 11K | 21.8K | SEC |
| 2025-12-05 | 12-05 | Luu Brendan | Chief Business Officer | S 公開市場賣出 | 1.4K | 14.23 | 20K | 38.3K | SEC |
| 2025-12-05 | 12-05 | Kieffer Tara Lynn | Chief Product Strategy Officer | S 公開市場賣出 | 2.1K | 14.23 | 30K | 30.6K | SEC |
| 2025-12-05 | 12-05 | Or Yat Sun | Chief Scientific Officer | S 公開市場賣出 | 2.4K | 14.23 | 34K | 371K | SEC |
| 2025-12-02 | 12-03 | Capps Kathleen S. | See Remarks | S 公開市場賣出 | 207 | 13.96 | 3K | 8.7K | SEC |
| 2025-12-02 | 12-03 | Trout Harry R. III | See Remarks | S 公開市場賣出 | 380 | 13.96 | 5K | 16.9K | SEC |
| 2025-12-01 | 12-03 | Luu Brendan | Chief Business Officer | F 繳稅扣股 | 498 | 14.12 | 7K | 39.7K | SEC |
| 2025-12-01 | 12-03 | Trout Harry R. III | See Remarks | F 繳稅扣股 | 105 | 14.12 | 1K | 17.3K | SEC |
| 2025-12-01 | 12-03 | Kieffer Tara Lynn | Chief Product Strategy Officer | F 繳稅扣股 | 753 | 14.12 | 11K | 32.7K | SEC |
| 2025-12-01 | 12-03 | Or Yat Sun | Chief Scientific Officer | F 繳稅扣股 | 753 | 14.12 | 11K | 374K | SEC |
| 2025-12-01 | 12-03 | Luly Jay R. | President and CEO | F 繳稅扣股 | 1.9K | 14.12 | 27K | 863K | SEC |
| 2025-12-01 | 12-03 | Capps Kathleen S. | See Remarks | F 繳稅扣股 | 85 | 14.12 | 1K | 8.9K | SEC |
| 2025-11-25 | 11-26 | Trout Harry R. III | See Remarks | A 獲配股票 | 6.5K | – | – | 17.4K | SEC |
| 2025-11-25 | 11-26 | Capps Kathleen S. | See Remarks | A 獲配股票 | 3.2K | – | – | 9.0K | SEC |
| 2025-08-08 | 08-08 | Rottinghaus Scott T. | Chief Medical Officer | F 繳稅扣股 | 2.2K | 6.99 | 15K | 22.6K | SEC |
| 2025-02-12 | 02-14 | Luly Jay R. | President and CEO | A 獲配股票 | 25.5K | – | – | 872K | SEC |
| 2025-02-12 | 02-14 | Luu Brendan | Chief Business Officer | F 繳稅扣股 | 3.3K | 5.59 | 19K | 40.2K | SEC |
| 2025-02-12 | 02-14 | Luu Brendan | Chief Business Officer | A 獲配股票 | 7.5K | – | – | 43.5K | SEC |
| 2025-02-12 | 02-14 | Kieffer Tara Lynn | Chief Product Strategy Officer | A 獲配股票 | 7.5K | – | – | 36.8K | SEC |
| 2025-02-12 | 02-14 | Rottinghaus Scott T. | Chief Medical Officer | F 繳稅扣股 | 2.9K | 5.59 | 16K | 24.8K | SEC |
| 2025-02-12 | 02-14 | Rottinghaus Scott T. | Chief Medical Officer | A 獲配股票 | 9.8K | – | – | 27.7K | SEC |
| 2025-02-12 | 02-14 | Or Yat Sun | Chief Scientific Officer | F 繳稅扣股 | 4.3K | 5.59 | 24K | 375K | SEC |
| 2025-02-12 | 02-14 | Or Yat Sun | Chief Scientific Officer | A 獲配股票 | 9.8K | – | – | 379K | SEC |
| 2025-02-12 | 02-14 | Kieffer Tara Lynn | Chief Product Strategy Officer | F 繳稅扣股 | 3.3K | 5.59 | 19K | 33.5K | SEC |
| 2025-02-12 | 02-14 | MELLETT PAUL J | Chief Fin. & Admin Officer | F 繳稅扣股 | 3.3K | 5.59 | 19K | 95.9K | SEC |
| 2025-02-12 | 02-14 | MELLETT PAUL J | Chief Fin. & Admin Officer | A 獲配股票 | 7.5K | – | – | 99.2K | SEC |
| 2025-02-12 | 02-14 | Luly Jay R. | President and CEO | F 繳稅扣股 | 7.5K | 5.59 | 42K | 865K | SEC |
| 2025-02-12 | 02-12 | Luly Jay R. | President and CEO | P 公開市場買進 | 45.0K | 5.69 | 256K | 847K | SEC |
| 2024-12-06 | 12-10 | MELLETT PAUL J | Chief Fin. & Admin Officer | S 公開市場賣出(10b5-1) | 2.6K | 8.06 | 21K | 91.7K | SEC |
| 2024-12-06 | 12-10 | Luly Jay R. | President and CEO | S 公開市場賣出(10b5-1) | 5.1K | 8.06 | 41K | 802K | SEC |
| 2024-12-06 | 12-10 | Kieffer Tara Lynn | Chief Product Strategy Officer | S 公開市場賣出(10b5-1) | 2.3K | 8.06 | 18K | 29.3K | SEC |
| 2024-12-06 | 12-10 | Luu Brendan | Chief Business Officer | S 公開市場賣出(10b5-1) | 2.3K | 8.06 | 18K | 36.0K | SEC |
| 2024-12-06 | 12-10 | Rottinghaus Scott T. | Chief Medical Officer | S 公開市場賣出(10b5-1) | 866 | 8.06 | 7K | 17.9K | SEC |
| 2024-12-06 | 12-10 | Or Yat Sun | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.6K | 8.06 | 21K | 369K | SEC |
| 2024-12-01 | 12-03 | Or Yat Sun | Chief Scientific Officer | F 繳稅扣股 | 1.6K | 8.60 | 14K | 372K | SEC |
| 2024-12-01 | 12-03 | Luu Brendan | Chief Business Officer | F 繳稅扣股 | 753 | 8.60 | 6K | 38.3K | SEC |
| 2024-12-01 | 12-03 | MELLETT PAUL J | Chief Fin. & Admin Officer | F 繳稅扣股 | 1.6K | 8.60 | 14K | 94.3K | SEC |
| 2024-12-01 | 12-03 | Luly Jay R. | President and CEO | F 繳稅扣股 | 3.8K | 8.60 | 33K | 807K | SEC |
| 2024-12-01 | 12-03 | Kieffer Tara Lynn | Chief Product Strategy Officer | F 繳稅扣股 | 753 | 8.60 | 6K | 31.6K | SEC |
| 2024-08-08 | 08-09 | Rottinghaus Scott T. | Chief Medical Officer | F 繳稅扣股 | 1.5K | 12.73 | 19K | 18.8K | SEC |
| 2024-07-15 | 07-15 | Rottinghaus Scott T. | Chief Medical Officer | M 選擇權執行 | 5.4K | 8.99 | 48K | 27.1K | SEC |
| 2024-07-15 | 07-15 | Rottinghaus Scott T. | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.4K | 17.08 | 92K | 21.7K | SEC |
| 2024-07-12 | 07-15 | Rottinghaus Scott T. | Chief Medical Officer | S 公開市場賣出(10b5-1) | 2.3K | 15.04 | 34K | 21.7K | SEC |
| 2024-07-11 | 07-15 | Rottinghaus Scott T. | Chief Medical Officer | S 公開市場賣出(10b5-1) | 4.3K | 15.07 | 65K | 24.0K | SEC |
| 2024-06-17 | 06-17 | Kieffer Tara Lynn | Chief Product Strategy Officer | S 公開市場賣出(10b5-1) | 7.3K | 12.33 | 90K | 32.3K | SEC |
| 2024-02-26 | 02-27 | Gardiner Nathaniel S. | Chief Legal Officer | M 選擇權執行 | 5.2K | 8.99 | 47K | 75.7K | SEC |
| 2024-02-12 | 02-14 | Kieffer Tara Lynn | Chief Product Strategy Officer | A 獲配股票 | 3.3K | – | – | 40.6K | SEC |
| 2024-02-12 | 02-14 | Gardiner Nathaniel S. | Chief Legal Officer | A 獲配股票 | 3.3K | – | – | 71.5K | SEC |
| 2024-02-12 | 02-14 | Rottinghaus Scott T. | Chief Medical Officer | F 繳稅扣股 | 755 | 12.41 | 9K | 28.3K | SEC |
| 2024-02-12 | 02-14 | Rottinghaus Scott T. | Chief Medical Officer | A 獲配股票 | 2.6K | – | – | 29.0K | SEC |
| 2024-02-12 | 02-14 | Or Yat Sun | Chief Scientific Officer | F 繳稅扣股 | 1.1K | 12.41 | 13K | 373K | SEC |
| 2024-02-12 | 02-14 | Or Yat Sun | Chief Scientific Officer | A 獲配股票 | 3.7K | – | – | 374K | SEC |
| 2024-02-12 | 02-14 | MELLETT PAUL J | Chief Fin. & Admin Officer | F 繳稅扣股 | 973 | 12.41 | 12K | 95.9K | SEC |
| 2024-02-12 | 02-14 | MELLETT PAUL J | Chief Fin. & Admin Officer | A 獲配股票 | 3.3K | – | – | 96.9K | SEC |
| 2024-02-12 | 02-14 | Luly Jay R. | President and CEO | F 繳稅扣股 | 1.6K | 12.41 | 20K | 811K | SEC |
| 2024-02-12 | 02-14 | Gardiner Nathaniel S. | Chief Legal Officer | F 繳稅扣股 | 973 | 12.41 | 12K | 70.5K | SEC |
| 2024-02-12 | 02-14 | Luly Jay R. | President and CEO | A 獲配股票 | 5.4K | – | – | 812K | SEC |
| 2024-02-12 | 02-14 | Kieffer Tara Lynn | Chief Product Strategy Officer | F 繳稅扣股 | 973 | 12.41 | 12K | 39.6K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Jupiter Topco LLC | 3.7M | 53.3M | 新進 | 新進 |
| BlackRock, Inc. | 3.2M | 47.3M | 新進 | 新進 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2.4M | 35.3M | 新進 | 新進 |
| Deep Track Capital, LP | 1.4M | 21.1M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 1.3M | 19.6M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | 17.7M | 新進 | 新進 |
| Spruce Street Capital LP | 1.1M | 15.9M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.0M | 14.7M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 777K | 11.3M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 644K | 9.4M | 新進 | 新進 |
| STATE STREET CORP | 576K | 8.4M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 558K | 8.1M | 新進 | 新進 |
| Hillsdale Investment Management Inc. | 468K | 6.8M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 465K | 6.8M | 新進 | 新進 |
| MORGAN STANLEY | 316K | 4.6M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 301K | 4.4M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 283K | 4.1M | 新進 | 新進 |
| NORTHERN TRUST CORP | 260K | 3.8M | 新進 | 新進 |
| SummitTX Capital, L.P. | 258K | 3.8M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 257K | 3.7M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 186K | 2.7M | 新進 | 新進 |
| Connor, Clark & Lunn Investment Management Ltd. | 153K | 2.2M | 新進 | 新進 |
| Rockefeller Capital Management L.P. | 151K | 2.2M | 新進 | 新進 |
| MARSHALL WACE, LLP | 132K | 1.9M | 新進 | 新進 |
| Opaleye Management Inc. | 125K | 1.8M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 122 -11 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 122 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 27.3M · 93.6% |
| 合計季末市值 | 339M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 2.6M |
|---|---|
| 與上期比 | -2.4% |
| 佔流通股數 | 8.98% |
| 日均成交量 | 258K |
| 回補天數 | 10.2 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 2.6M | -2.4% | 8.98% | 258K | 10.2 |
| 2026-08-14 | 2.7M | +3.6% | 9.20% | 182K | 14.7 |
| 2026-07-31 | 2.6M | +6.0% | 8.88% | 146K | 17.7 |
| 2026-07-15 | 2.4M | -5.5% | 8.38% | 191K | 12.8 |
| 2026-06-30 | 2.6M | +6.4% | 8.87% | 319K | 8.1 |
| 2026-06-15 | 2.4M | +6.7% | 8.33% | 190K | 12.8 |
| 2026-05-29 | 2.3M | +3.3% | 7.81% | 207K | 11.0 |
| 2026-05-15 | 2.2M | +2.2% | 7.56% | 235K | 9.4 |
| 2026-04-30 | 2.2M | +2.6% | 7.40% | 115K | 18.8 |
| 2026-04-15 | 2.1M | -1.5% | 7.22% | 122K | 17.3 |
| 2026-03-31 | 2.1M | -1.4% | 7.32% | 137K | 15.5 |
| 2026-03-13 | 2.2M | -1.1% | 7.43% | 193K | 11.2 |
| 2026-02-27 | 2.2M | -3.9% | 7.51% | 181K | 12.1 |
| 2026-02-13 | 2.3M | +0.7% | 7.81% | 196K | 11.6 |
| 2026-01-30 | 2.3M | +0.3% | 7.76% | 221K | 10.2 |
| 2026-01-15 | 2.3M | +8.2% | 7.74% | 266K | 8.5 |
| 2025-12-31 | 2.1M | -8.8% | 7.15% | 468K | 4.5 |
| 2025-12-15 | 2.3M | -7.9% | 7.84% | 296K | 7.7 |
| 2025-11-28 | 2.5M | -11.5% | 8.52% | 327K | 7.6 |
| 2025-11-14 | 2.8M | +2.5% | 9.62% | 298K | 9.4 |
| 2025-10-31 | 2.7M | -2.8% | 9.39% | 524K | 5.2 |
| 2025-10-15 | 2.8M | -16.0% | 9.66% | 836K | 3.4 |
| 2025-09-30 | 3.4M | +17.6% | 11.50% | 2.0M | 1.7 |
| 2025-09-15 | 2.8M | +0.5% | 9.78% | 207K | 13.8 |
| 2025-08-29 | 2.8M | -1.8% | 9.73% | 143K | 19.8 |
| 2025-08-15 | 2.9M | +5.6% | 9.91% | 145K | 19.9 |